Hormone Receptor Positive Tumor Recruiting Phase 3 Trials for Ribociclib (DB11730)

IndicationStatusPhase
DBCOND0075370 (Hormone Receptor Positive Tumor)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03462251Ribociclib and Aromatase Inhibitor or Paclitaxel and Bevacizumab for Metastatic Breast Cancer in First LineTreatment